New processing-in-memory technology pushes the company toward next-generation robotics and edge-AI applications

DorsaVi Ltd (ASX: DVL) has taken a significant strategic step with the acquisition of neuromorphic processing-in-memory (PIM) intellectual property from Technion in Israel — technology led by Professor Shahar Kvatinsky, one of the semiconductor industry’s most prominent neuromorphic hardware researchers. This move positions DorsaVi at the forefront of a rapidly expanding sector, with the global neuromorphic computing market forecast to grow from US$5.3bn in 2023 to more than US$20bn by 2030.

For long-term followers of the company, this represents a major technological leap. Neuromorphic PIM integrates computation directly inside the memory layer, enabling chips to “sense, think, and act” without relying on external cloud processing. This architecture mimics biological neurons and allows computation to occur only when a meaningful event is detected — offering substantial gains in energy efficiency, latency reduction and performance. In DorsaVi’s existing biosensor business, this could allow wearables to interpret movement patterns, adjust to an individual’s biomechanics, and deliver real-time insights, all at the edge rather than via the cloud.

Beyond wearables, the acquisition opens a much broader long-term opportunity: robotics. Industry forecasts suggest humanoid and industrial robots could evolve into a multi-trillion-dollar segment over the next two decades, with demand for brain-like computing architectures increasing significantly. Neuromorphic PIM offers millisecond-level reflex speeds — enabling robots to react instantly to stimuli — while reducing power consumption, thermal load and the reliance on cloud infrastructure. These characteristics align closely with what next-generation robotic platforms are expected to require.

Pitt Street Research reiterates its Sum-of-the-Parts valuation of A$0.22 per share, with A$0.13 per share attributed to the Sensor business and A$0.09 per share to the ReRAM business. While the newly acquired neuromorphic IP does not immediately alter this valuation, it strengthens the company’s competitive positioning and introduces new IP-driven pathways — including potential licensing to semiconductor manufacturers, OEMs, and robotics companies, where upfront fees and per-unit royalties could create a high-margin revenue model. Key catalysts include ReRAM development updates, new semiconductor partnerships, and additional commercial contracts for the clinical sensor division.

As with all early-stage technology companies, risks remain — including competition from alternative emerging memory technologies, funding requirements, operational execution, and the need to build a specialised semiconductor and robotics talent base. However, the acquisition of neuromorphic PIM IP represents a meaningful shift in the company’s strategic trajectory and provides multi-year optionality well beyond its core sensor business.

For the full valuation model, development roadmap, catalysts and key risks, download the complete DorsaVi research report.